Drugs Archives - Page 43 of 65 - ��ýҕ�l Health News

Podcast: KHN’s ‘What The Health?’ A ‘Healthy’ State Of The Union

Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.

Feb. 7, 2019

Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale

President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.

By Sydney Lupkin and Jay Hancock

Feb. 7, 2019

Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices

The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.

By Julie Rovner

Feb. 6, 2019

Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals

The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.

By Jay Hancock

Feb. 1, 2019

Lawsuit Details How The Sackler Family Allegedly Built An OxyContin Fortune

WBUR and other media organizations sued Purdue Pharma to force the release of previously redacted information in a case brought by the Massachusetts attorney general.

By Christine Willmsen, WBUR and Martha Bebinger, WBUR

Feb. 1, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Feb. 1, 2019

Podcast: KHN’s ‘What The Health?’ Live From D.C.: A Look Ahead At Health Policy In 2019

Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN’s Julie Rovner to discuss these issues and take questions from a live studio audience.

Jan. 31, 2019

Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs

Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.

By Emmarie Huetteman and Rachel Bluth

Jan. 29, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Jan. 25, 2019

Drug-Pricing Policies Find New Momentum As ‘A 2020 Thing’

Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.

By Shefali Luthra

Jan. 25, 2019

Listen: ‘Death Certificate Project’ Aims At Opioid Crisis, But Doctors Cry Foul

A radio report on an effort in California to hold doctors responsible when a patient overdoses on opioids. Doctors say it is unfair, but the state medical board defends the new project.

By April Dembosky, KQED

Jan. 23, 2019

Doctors Call California’s Probe Of Opioid Deaths A ‘Witch Hunt’

In a unique crackdown on what it sees as “excessive prescribing,” the state medical board is investigating hundreds of doctors whose patients ultimately died of opioid overdoses — whether or not the doctors prescribed the fatal medications.

By Cheryl Clark

Jan. 23, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Jan. 18, 2019

County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing

A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.

By Victoria Knight

Jan. 18, 2019

Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach

Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.

By Jay Hancock and Sydney Lupkin

Jan. 18, 2019

Podcast: KHN’s ‘What The Health?’ Drug Prices Are Rising Again. Is Someone Going To Do Something About It?

As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.

Jan. 17, 2019

Meth’s Resurgence Spotlights Lack Of Meds To Combat The Addiction

While headlines continue to focus on the nation’s opioid crisis, a growing toll of overdoses and deaths related to methamphetamine use suggests this drug is making an under-the-radar comeback.

By Carmen Heredia Rodriguez

Jan. 14, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Jan. 11, 2019

Letters to the Editor

Bills, Bills, Bills: Readers And Tweeters Offer Solace, Solutions And Scoldings

Kaiser Health News gives readers a chance to comment on a recent batch of stories.

Jan. 11, 2019

Emergency Medical Responders Confront Racial Bias

In a recent study of patients treated by emergency medical responders in Oregon, black patients were 40 percent less likely to get pain medicine than their white peers. Why?

By Kristian Foden-Vencil, Oregon Public Broadcasting

Jan. 11, 2019

��ýҕ�l

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs